Paradice Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.3M Sell
491,265
-36,790
-7% -$3.3M 7.95% 1
2025
Q4
$46.1M Sell
528,055
-134,983
-20% -$10.2M 8.98% 1
2025
Q3
$38M Buy
663,038
+114,433
+21% +$6.59M 8.52% 1
2025
Q2
$32.4M Buy
548,605
+113,958
+26% +$7.36M 6.58% 5
2025
Q1
$31.8M Sell
434,647
-2,033
-0.5% -$168K 7.11% 3
2024
Q4
$36.1M Sell
436,680
-157,430
-26% -$12.4M 7.17% 2
2024
Q3
$42.5M Sell
594,110
-36,712
-6% -$2.59M 7.4% 1
2024
Q2
$43.2M Sell
630,822
-10,239
-2% -$612K 7.64% 1
2024
Q1
$34.4M Sell
641,061
-120,775
-16% -$6.49M 5.96% 3
2023
Q4
$40.6M Sell
761,836
-346,979
-31% -$16.9M 5.1% 5
2023
Q3
$55.1M Buy
+1,108,815
New +$62M 4.72% 7

Other funds holding GMED

Paradice Investment Management's GMED Position: Q1 2026 in Review

Paradice Investment Management reduced its Globus Medical (GMED) stake by 7% in Q1 2026, selling an estimated $3.3M and leaving 491,265 shares worth $42.3M. The position accounts for 7.95% of the portfolio, ranked #1.

Paradice Investment Management first reported a position in GMED in Q3 2023 and has held it in 11 quarters since. The position peaked at $55.1M in Q3 2023. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Paradice Investment Management held 491,265 shares of Globus Medical worth $42.3M as of Q1 2026.
  • Paradice Investment Management sold 36,790 Globus Medical shares in Q1 2026, an estimated $3.3M.
  • Globus Medical made up 7.95% of Paradice Investment Management's portfolio in Q1 2026, its #1 holding.
  • Paradice Investment Management first reported a position in Globus Medical in Q3 2023 and has held it in 11 quarters since.
  • Paradice Investment Management's Globus Medical position peaked at $55.1M in Q3 2023.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Paradice Investment Management's 13F filing for Q1 2026, filed 15 May 2026.